News and Announcements.
Articles
Case study featuring Reboot Rx by Amazon Web Services and The Chronicle of Philanthropy - January 2024
Laura Kleiman’s Op-Ed in The Boston Globe - December 2023
Reboot Rx featured in Inside Philanthropy - April 2023
Reboot Rx discussed in the Harvard Business Review - April 2023
Reboot Rx featured in Life Science Leader - September 2022
Boston Business Journal feature on Laura Kleiman - October 2021
Boston Business Journal Women Who Lead in Life Sciences panel - October 2021
Story by the Massachusetts Life Sciences Center about our work - September 2021
Reboot Rx’s Prostate Cancer Project featured in Drug Discovery News - September 2021
Policy proposal published by the Day One Project - April 2021
Reboot: COVID-Cancer Project covered by The ASCO Post, Oncology Times, and OncLive - March 2021
Starting a company from scratch in Databird Business Journal - October 2020
Forbes feature on Laura Kleiman - September 2020
Research articles in the Proceedings of the AAAI Conference on Artificial Intelligence and arXiv - April 2020
BostInno’s one of five social impact startups to watch - November 2019
Reboot Rx’s collaboration with AI researchers at IBM’s Science for Social Good Initiative - July 2019
Impact investing and venture philanthropy in Pharmaceutical Executive - May 2019
Press releases
Reboot Rx receives grants totaling $1 million - April 2023
Laura Kleiman named Class of 2022 Henri Termeer Fellow - April 2022
Laura Kleiman named Extraordinary Women Advancing Healthcare Honoree - June 2021
Reboot Rx selected for the Massachusetts Next Generation Initiative Award - June 2021
Laura Kleiman named a CHM Patrick J. McGovern Tech for Humanity Prize Changemaker finalist - April 2021
Laura Kleiman selected as a recipient of the 40 Under 40 in Cancer Award - January 2021
Reboot Rx announced as a winner of the New England Innovation Awards - November 2020
Reboot Rx launched the Reboot: COVID-Cancer Project - August 2020
Reboot Rx selected for the Fast Forward Accelerator - July 2020
Reboot Rx selected for The Greater Sum Foundation 2020 cohort - January 2020
Reboot Rx named a MassChallenge Top 20 startup - October 2019
Podcasts
Impact AI - February 2023
Startups for Good - April 2021
Founded by Women - March 2021
Breast Cancer Conversations - January 2021
Talking Precision Medicine - August 2020
Contact: media@rebootrx.org
Presentations
2023
December: Dana-Farber Cancer Institute
November: American Cancer Society BrightEdge Summit
June: BIO International Convention
April: Boston University
February: Brown University
2022
November: 10th Annual Drug Repositioning and Repurposing Conference
November: Brown University
June: Rancho BioSciences
June: Mission: Cure
May: FDA Generic Drug Science and Research Initiatives Workshop
April: Skoll World Forum Ecosystem Day
March: Northeastern University
March: Brown University
February: Boston Business Journal Bizwomen Mentoring Monday
January: WuXi Global Forum “Investing for Social Impact” panel
2021
November: University College London Therapeutic Innovation Network seminar "Innovative thinking and approaches to accelerate drug repurposing"
November: Tri-Institute (Cornell/Rockefeller/MSKCC) Drug Discovery and Repurposing Panel
October: Prostate Cancer Foundation Scientific Retreat
October: Boston Business Journal Women Who Lead in Life Sciences
July: Mission: Cure
June: Davis Institute for Artificial Intelligence at Colby College
May: Moffitt Cancer Center Career Development Panel on Entrepreneurship
May: STAT Health Tech Summit
May: CPhI Discover
April: AI-Driven Drug Repurposing and Repositioning Summit
February: Using AI for Good panel at General Assembly’s Tech Week
February: Workshop on Scientific Document Understanding at the AAAI Conference on Artificial Intelligence
February: AAAI Conference on Artificial Intelligence Demonstration Program
February: American Association for Cancer Research COVID-19 and Cancer Virtual Meeting
January: PhD's in Tech Research panel at MIT
2020
November: Harvard Medical School & Harvard Business School class “Medicine and Management”
November: Judge for the MassBio Life Sciences & Healthcare Nonprofit Pitch Challenge
October: Innovation during Uncertain Times panel at Greater Summit 2020
October: New England Innovation Showcase
September: Annual Drug Repositioning and Repurposing Conference
September: Fast Forward Demo Day
August: COVID-19 and Cancer Consortium (CCC19)
June: Mission: Cure
April: International Conference on Learning Representations (ICLR-2020)
March: SEI-Boston International Women's Day Celebration
February: Annual Conference on Innovative Applications of Artificial Intelligence (IAAI)
February: Hosted a challenge project at TechTogether Boston
January: Northeastern University class “Understanding Design”
2019
December: Machine Learning for Health (ML4H) Workshop at NeurIPS
December: Westchester Biotech Project Virtual Roundtable: Data Science for the Public Good
December: Participated in FDA & NCATS workshop “Repurposing Off-Patent Drugs: Research & Regulatory Challenges”
November: New York Academy of Sciences “Natural Language, Dialog and Speech” Symposium
November: Harvard Nonprofit Research Panel
November: Harvard Medical School & Harvard Business School class “Medicine and Management”
October: MIT Center for Precision Cancer Medicine
October: MassChallenge Awards Ceremony
October: Hosted a Brandeis Business School case competition
September: Annual Drug Repositioning and Repurposing Conference
August: FDA’s Oncology Center of Excellence Drug Repurposing for Oncology Rare Diseases Mini-Symposium
August: IBM Research
July: “Intro to the Boston Startup Community” panel at General Assembly
July: MassChallenge Startup Showcase
May: Harvard Big Data Club
April: MIT-Harvard Ideation
2018
September: Broad Institute of MIT and Harvard
March: Charity Warriors Challenge
2017
November: Dana-Farber Cancer Institute
October: Strategic Partnerships for Drug Repurposing Forum
September: European Center of Pharmaceutical Medicine in Switzerland
June: Annual Drug Repositioning and Repurposing Conference
Awards
New England Innovation Award
Reboot Rx was announced as a winner of the 2020 New England Innovation Award, the longest-running innovation program in New England.
40 Under 40 in Cancer
CEO Laura Kleiman was selected as a recipient of the 40 Under 40 in Cancer Award, which recognizes rising stars and emerging leaders in oncology. 2020 award sponsors include Value-Based Cancer Care, Swim Across America, The Lynx Group, Upstream Partners, and National Community Oncology Dispensing Association.
MassChallenge
Reboot Rx, formerly Cures Within Reach for Cancer, was named a silver winner of MassChallenge, one of the largest startup accelerators in the world. Voted the 2019 MassChallenge-Boston startup most likely to change the world.
MassBio
Cures Within Reach for Cancer won the 2018 MassBio Petri Dish Nonprofit Pitch Challenge.
Dana-Farber Cancer Institute
CEO Laura Kleiman was honored with the Dana-Farber Cancer Institute's 2018 Community Service Award.